The global oxygen therapy market was valued at USD 37.20 Billion in 2024, driven by the introduction of favourable government incentives to aid the treatment of chronic illness and provide required supplement oxygen across the globe. The market is anticipated to grow at a CAGR of 6.83% during the forecast period of 2025-2034 to achieve a value of USD 72.02 Billion by 2034.
Europe is also poised to witness growth, with strong demand from countries like Germany, the UK, and France. Factors such as rising chronic disease incidences, government healthcare investments, and advancements in oxygen therapy technologies drive the market in Europe, ensuring steady growth.
Other key players in the market include Becton, Dickinson and Company, Smith Pharmacy, Drägerwerk AG & Co. KGaA, Teleflex Incorporated, and Fisher & Paykel Healthcare Corporation Limited.
This product will be delivered within 3-5 business days.
Oxygen Therapy Market Overview
Oxygen therapy is a medical treatment that provides extra oxygen to individuals with low oxygen levels in their blood. It is commonly used for conditions like chronic obstructive pulmonary disease (COPD), pneumonia, or sleep apnea. The therapy helps improve oxygen saturation, enhancing breathing and overall organ function. Oxygen can be administered through nasal prongs, face masks, or more advanced devices like ventilators, depending on the severity of the condition. It is typically prescribed by a healthcare professional to ensure safe and effective use tailored to individual needs.Oxygen Therapy Market Growth Drivers
Increasing Research and Clinical Trials Enhance the Oxygen Therapy Market
As the global focus shifts towards enhancing treatment options for neurological conditions and improving patient care, the oxygen therapy market is set to expand. For instance, In December 2024, USF Health initiated a state-funded clinical trial exploring the impact of hyperbaric oxygen therapy (HBOT) on Florida service members and veterans suffering from traumatic brain injury (TBI). This five-year study, which is among the most rigorous of its kind, could provide critical insights into the effectiveness of HBOT in treating neurological diseases. The results from this large-scale trial, if successful, will likely drive greater adoption of hyperbaric oxygen therapy, increasing demand and shaping the market for neurological treatments.Technological Advancements in Portable Oxygen Concentrators to Fuel Oxygen Therapy Market Value
Technological advancements are a key driver of the oxygen therapy market's expansion, particularly in homecare settings. For instance, in October 2024, Inogen, launched the Inogen Rove 4™ Portable Oxygen Concentrator, designed to offer enhanced functionality and flexibility for patients requiring medical oxygen. With its lightweight design, multiple battery configurations, and the ability to deliver up to 840 ml/min of oxygen, the device offers patients greater mobility and convenience. The launch of such advanced, user-friendly products is expected to expand the market by empowering patients to continue their daily activities with ease, driving the growth of portable oxygen devices in homecare markets globally.Oxygen Therapy Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:Rising Respiratory Disorders Fuel Significant Growth in the Market
The market is expanding due to the increasing prevalence of chronic respiratory diseases like COPD and asthma. As air pollution levels rise and the global aging population grows, the demand for oxygen therapy products, such as oxygen concentrators and cylinders, is rising. With advancements in technology, oxygen therapy devices have become more portable and cost-effective, further driving their adoption. Moreover, increasing awareness about respiratory health and early detection of diseases is leading to earlier treatments, boosting the overall market growth. Healthcare infrastructure improvements in developing regions are also contributing to this expansion.Technological Innovations to Augment Europe Compression Bandages Market Demand
Technological innovation is a major driver of development in the market. The introduction of portable oxygen concentrators and non-invasive oxygen delivery systems has improved patient mobility and comfort. These devices are more efficient, user-friendly, and affordable, appealing to a broader consumer base. Moreover, the integration of IoT (Internet of Things) technology allows real-time monitoring and remote adjustments, enhancing patient care. This trend is especially beneficial for home healthcare settings, where patients require continuous, non-invasive oxygen supply. These technological developments are reshaping the market, offering more effective solutions and expanding the consumer base.Preference for Homecare and Remote Monitoring to Drive Oxygen Therapy Market Value
The home healthcare sector is witnessing rapid growth, significantly impacting the market value. With the increasing preference for home care, particularly in the elderly population, portable oxygen devices are becoming more sought after. Remote monitoring technologies are allowing healthcare providers to track patients’ oxygen levels, ensuring consistent treatment without requiring frequent hospital visits. This shift towards homecare has resulted in a surge in the demand for oxygen concentrators, pulse oximeters, and other related devices. As homecare services become more mainstream, the market value for oxygen therapy products is expected to see steady increases.Expanding Healthcare Access in Emerging Economies to Boost Europe Compression Bandages Market Growth
Emerging economies are a key focus for the expansion of the market. As healthcare infrastructure improves and disposable income rises in regions such as Asia-Pacific, Latin America, and Africa, the adoption of advanced healthcare solutions, including oxygen therapy, is accelerating. Governments are increasingly investing in healthcare access, making oxygen therapy more accessible in remote and underserved areas. Additionally, the demand for oxygen therapy devices is rising with the increasing number of hospitals, clinics, and homecare services in these regions. This geographic expansion offers significant growth opportunities for the market.Oxygen Therapy Market Segmentation
Oxygen Therapy Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:Market Breakup by Product
- Oxygen Source Equipment
- Liquid Oxygen Devices
- Oxygen Cylinders
- Oxygen Concentrators
- PAP Devices CPAP APAP Bi-PAP
- Oxygen Delivery Devices
- Oxygen Masks
- Venturi Masks
- Bag-Valve Masks
- Non-Breather Masks
- Nasal Cannulas
- Others
Market Breakup by Portability
- Stationary Devices
- Portable Devices
Market Breakup by Application
- Asthma
- Pneumonia
- Cystic Fibrosis
- Respiratory Distress Syndrome
- Obstructive Sleep Apnea
- Chronic Obstructive Pulmonary Disease
- Others
Market Breakup by End User
- Hospitals and Clinics
- Ambulatory Surgical Centers (ASCs)
- Homecare Settings
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Oxygen Therapy Market Share
Market Share by Product to Undergo Notable Growth
Oxygen source equipment, especially oxygen concentrators are expected to hold a notable market share due to their growing demand in both homecare and hospital settings. The increasing prevalence of chronic respiratory diseases, such as COPD and asthma, has significantly driven the adoption of oxygen concentrators. These devices offer continuous oxygen supply, making them essential for long-term therapy. With advancements in technology, newer, more efficient models are emerging, fuelling their market growth. The demand for portable oxygen concentrators, offering greater convenience, is poised to drive further growth in the forecast period, solidifying this segment’s dominance.Oxygen Therapy Market by Portability to Undergo Significant Growth
Portable devices are the leading segment in oxygen therapy by portability, driven by the increasing need for flexible, on-the-go solutions for patients with chronic respiratory conditions. Portable oxygen concentrators and cylinders allow patients to maintain mobility whilez receiving therapy, which is crucial for improving their quality of life. The rising elderly population and growing awareness of portable oxygen solutions are significant drivers. Future growth is expected from innovations in lightweight, battery-efficient devices, which will continue to enhance patient experience and support the increasing trend towards homecare and ambulatory care settings, leading to market expansion.Chronic Obstructive Pulmonary Disease to Lead the Oxygen Therapy Market Segmentation by Application
Chronic Obstructive Pulmonary Disease (COPD) is the leading application segment for oxygen therapy, primarily due to its high prevalence globally. COPD patients require long-term oxygen therapy to improve oxygen saturation levels, particularly during the advanced stages of the disease. The rising incidence of smoking-related diseases and air pollution contributes to the expanding patient base. With increasing awareness and improved diagnostic methods, more patients are being identified early, leading to a higher demand for oxygen therapy. As COPD continues to be a major health concern, this segment is set for continued market growth throughout the forecast period.Hospitals and Clinics to Hold a Major Share of the End User Segment
Hospitals and clinics remain the dominant end-user segment for oxygen therapy, as these settings manage critical patients with respiratory diseases requiring intensive treatment. The continuous increase in hospital admissions due to respiratory diseases and the need for medical interventions contribute to the high market share in this segment. Furthermore, advancements in hospital infrastructure and the adoption of modern oxygen therapy devices are driving this trend. As the healthcare sector continues to prioritise respiratory care, particularly post-pandemic, hospitals and clinics are poised to maintain their leadership, further accelerating market growth in the coming years.Oxygen Therapy Market Analysis by Region
The North American region will likely hold a notable market share, primarily driven by advanced healthcare infrastructure, high healthcare spending, and a well-established regulatory environment. The growing prevalence of respiratory diseases, such as COPD and asthma, further propels the demand for oxygen therapy solutions. Additionally, increasing awareness about the benefits of oxygen therapy, coupled with the ageing population, enhances market growth. The presence of leading oxygen therapy equipment manufacturers and extensive insurance coverage also contributes to North America's dominance.Europe is also poised to witness growth, with strong demand from countries like Germany, the UK, and France. Factors such as rising chronic disease incidences, government healthcare investments, and advancements in oxygen therapy technologies drive the market in Europe, ensuring steady growth.
Leading Players in the Oxygen Therapy Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:Philips Healthcare
Headquartered in Amsterdam, Netherlands, Philips Healthcare, established in 1891, is a global leader in medical technology and healthcare solutions. The company offers a comprehensive portfolio in the oxygen therapy market, including portable oxygen concentrators, oxygen delivery systems, and patient monitoring solutions. Philips focuses on improving patient outcomes and comfort through innovative respiratory care solutions. Their products are widely used in home care, hospitals, and long-term care facilities, with an emphasis on integrating advanced technology like cloud-based monitoring and remote patient management to enhance treatment efficiency.Linde Healthcare
Linde Healthcare, a division of Linde plc, is headquartered in Munich, Germany, and was founded in 1879. As a major player in the global oxygen therapy market, Linde provides a wide range of products and services, including medical oxygen, oxygen concentrators, and respiratory therapy solutions. The company focuses on delivering high-quality healthcare through its advanced oxygen delivery systems, catering to both homecare patients and hospitals. Linde also offers comprehensive support services, including training, technical assistance, and remote monitoring, aiming to improve patient care and treatment outcomes.Chart Industries, Inc
Chart Industries, established in 1992 and headquartered in Ball Ground, Georgia, USA, is a leading manufacturer of oxygen therapy equipment and cryogenic products. Its portfolio includes oxygen concentrators, cryogenic oxygen storage systems, and liquid oxygen solutions. Chart Industries provides innovative solutions for both medical and industrial gas applications, with a strong focus on improving the efficiency and safety of oxygen therapy delivery. The company serves healthcare providers, homecare patients, and hospitals, developing sustainable and cost-effective oxygen delivery systems to enhance patient comfort and treatment effectiveness.Invacare Corporation
Invacare Corporation, founded in 1885 and headquartered in Elyria, Ohio, USA, is a prominent player in the oxygen therapy market. The company offers a wide range of respiratory products, including portable oxygen concentrators, home oxygen systems, and ventilators. Invacare’s focus is on providing high-quality, reliable homecare solutions to patients with respiratory conditions, ensuring their independence and comfort. Their products are widely used in home healthcare and institutional settings, and the company is committed to delivering innovation and support services to enhance the overall patient experience in oxygen therapy.Other key players in the market include Becton, Dickinson and Company, Smith Pharmacy, Drägerwerk AG & Co. KGaA, Teleflex Incorporated, and Fisher & Paykel Healthcare Corporation Limited.
Key Questions Answered in the Oxygen Therapy Market
- What was the oxygen therapy market value in 2024?
- What is the oxygen therapy market forecast outlook for 2025-2034?
- What is market segmentation based on product?
- How is the market segmented based on portability?
- How is the market segmented based on application?
- How is the market segmented based on the end users?
- What are the major factors aiding the oxygen therapy market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major oxygen therapy market trends?
- Which product will lead the market segment?
- Which portability will lead the market segment?
- Which application will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the oxygen therapy market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Global Oxygen Therapy Market Overview
4 Vendor Positioning Analysis
5 Global Oxygen Therapy Market Landscape*
6 Global Oxygen Therapy Market Dynamics
7 Global Oxygen Therapy Market Segmentation (218-2034)
8 North America Oxygen Therapy Market (2018-2034)
8 Europe Oxygen Therapy Market (218-2034)
9 Asia Pacific Oxygen Therapy Market (218-2034)
10 Latin America Oxygen Therapy Market (218-2034)
11 Middle East and Africa Oxygen Therapy Market (218-2034)
12 Patent Analysis
13 Grants Analysis
14 Funding and Investment Analysis
15 Strategic Initiatives
16 Supplier Landscape
17 Global Oxygen Therapy Market - Distribution Model (Additional Insight)
Companies Mentioned
- Philips Healthcare
- Linde Healthcare
- Chart Industries, Inc.
- Invacare Corporation
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 400 |
Published | June 2025 |
Forecast Period | 2025 - 2034 |
Estimated Market Value ( USD | $ 37.2 Billion |
Forecasted Market Value ( USD | $ 72.02 Billion |
Compound Annual Growth Rate | 6.8% |
Regions Covered | Global |
No. of Companies Mentioned | 4 |